Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide.
about
Mitochondria-Targeted Antioxidants: Future Perspectives in Kidney Ischemia Reperfusion InjuryCardiac dysfunction and oxidative stress in the metabolic syndrome: an update on antioxidant therapiesMitochondrial oxidative stress in aging and healthspanTargeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesisFirst-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergeticsSerendipity and the discovery of novel compounds that restore mitochondrial plasticityThe mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipinMitochondrial dysfunction in cardiac agingElectron flow into cytochrome c coupled with reactive oxygen species from the electron transport chain converts cytochrome c to a cardiolipin peroxidase: role during ischemia-reperfusionRegulation of the transcription factor EB-PGC1α axis by beclin-1 controls mitochondrial quality and cardiomyocyte death under stressCardioprotective Effects of Mitochondria-Targeted Peptide SBT-20 in two Different Models of Rat Ischemia/Reperfusion.Reduction of early reperfusion injury with the mitochondria-targeting peptide bendaviaMitochondrial protection restores renal function in swine atherosclerotic renovascular disease.Mitochondrial uncoupling does not decrease reactive oxygen species production after ischemia-reperfusion.Targeting CD36-mediated inflammation reduces acute brain injury in transient, but not permanent, ischemic stroke.Mitochondrial reactive oxygen species at the heart of the matter: new therapeutic approaches for cardiovascular diseases.Induction of cardioprotection by small netrin-1-derived peptidesExercise-induced protection against reperfusion arrhythmia involves stabilization of mitochondrial energeticsChronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.Administration of antioxidant peptide SS-31 attenuates transverse aortic constriction-induced pulmonary arterial hypertension in mice.Restoration of Mitochondrial Cardiolipin Attenuates Cardiac Damage in Swine Renovascular HypertensionBendavia restores mitochondrial energy metabolism gene expression and suppresses cardiac fibrosis in the border zone of the infarcted heart.Mechanisms of exercise-induced cardioprotection.Mitochondrial targeted peptides attenuate residual myocardial damage after reversal of experimental renovascular hypertension.Expert consensus document: Mitochondrial function as a therapeutic target in heart failurePharmacological approaches to the treatment of oxidative stress-induced cardiovascular dysfunctions.Myocardial energetics in heart failure.Cardioprotection against myocardial reperfusion injury: successes, failures, and perspectives.Is further improvement of the treatment of acute coronary syndromes still possible?Targeting mitochondria for cardioprotection: examining the benefit for patients.Crosstalk of mitochondria with NADPH oxidase via reactive oxygen and nitrogen species signalling and its role for vascular function.New pharmacological approaches in heart failure therapy: developments and possibilities.Metabolic support for the heart: complementary therapy for heart failure?Mitochondria in Structural and Functional Cardiac Remodeling.Exercise: Teaching myocytes new tricks.The Slo(w) path to identifying the mitochondrial channels responsible for ischemic protection.The role of succinate and ROS in reperfusion injury - A critical appraisal.Paeonol Protects Rat Heart by Improving Regional Blood Perfusion during No-ReflowMitochondrial therapy improves limb perfusion and myopathy following hindlimb ischemia.Co-administration of the flavanol (-)-epicatechin with doxycycline synergistically reduces infarct size in a model of ischemia reperfusion injury by inhibition of mitochondrial swelling.
P2860
Q26744639-A4A8C7B6-C742-43E5-B33C-EA1FE7CDB250Q27002459-A4F391A9-4D91-411C-B887-6F7661692EFFQ27025099-0E5B560A-9456-438E-9587-BF464E5E9129Q28383442-5C5C60BC-E94D-4BAB-9AF7-1AEE2551A7A1Q28383451-5B3F0271-8954-4ACF-B58B-8D5FC3D6F7BBQ28384256-CF80C9E9-02C4-496D-9672-C5DC0071608FQ28387020-DE7FB20A-9039-4275-BD69-CA7BB4D98737Q28389063-2C303C8F-673E-4B97-A001-5E892D15E1E6Q28390353-73FBDAD3-EB18-4A41-98A9-B6A1322A7567Q28576723-56514374-19B5-4201-BC58-FD39FD2B5E84Q33883312-7026234C-2B37-4CA4-BA25-2EC994E47934Q33919143-C5757B8C-B898-431F-BA9B-737085709A36Q34137989-D3730286-9D92-4442-ACA9-3F0571C52CF1Q34295467-AED37040-B326-49FD-9085-198D9A2187AEQ35185434-5132C894-A58A-44EA-9356-85D32EB56FFDQ35645530-BF080EE6-5B9B-417D-86D7-301B0167FAF4Q35859191-7BB128E1-57DA-4EC0-99C9-6205F9D7FD7AQ35946411-4ABAA4E9-E7E5-49E2-9857-749B4F27380FQ36550830-43A2A527-EB68-4BE5-A45C-134B88278E45Q36872140-CB1BE8D1-B03B-4574-80F0-0908E2B6DF66Q37076104-9718FDD4-0AFF-4997-8725-D6F5D9E001AFQ37151412-1B06488C-0F02-44B9-86AC-E20C26DD8FC4Q37593103-9F31A7CD-F840-4E76-BDD5-734616F0090CQ37686149-1E964A54-D741-42E0-84B6-58D620E2FF21Q37699474-445094BB-41B0-4680-BD64-E8FE59D36296Q38089739-6ACD1EAB-511C-4BB9-AB9C-3D3116C7529CQ38112349-9EB406BD-B61E-4F7D-A767-5180E82CC2B4Q38124357-4ABDBC1E-DB73-46D1-B2FA-9CC71F778F14Q38191214-4E7D2D2D-B730-4994-9860-F3EBF6796C4BQ38206842-26E6858A-E4CB-4B23-ADAB-074031C28F59Q38667506-9936786F-0260-4621-9CFA-6F5736B83C70Q38759494-7FDF638C-AF71-46EB-93B5-0EFDB70D50FAQ38998576-54B37925-ABF8-4A7D-95A5-A1347D5A361CQ39334539-7F958F60-32DB-4813-9580-1F18C7153308Q39345059-EFEC85E6-8A9D-4C54-8950-D16A0F7C5704Q39363477-970E37C7-777D-435B-B8B6-A9E9E751F5F8Q39423100-E4D8C61A-0964-44C7-81DA-9012B0322FD7Q39521563-A54238DC-E894-4795-A7AE-B73C342B858FQ40961867-F6F8A453-776D-49CA-BAA0-2382B28B42E9Q42368628-BB0813B9-4F65-4A56-96AA-CC389C4499B1
P2860
Reduction of ischemia/reperfusion injury with bendavia, a mitochondria-targeting cytoprotective Peptide.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Reduction of ischemia/reperfus ...... geting cytoprotective Peptide.
@ast
Reduction of ischemia/reperfus ...... geting cytoprotective Peptide.
@en
type
label
Reduction of ischemia/reperfus ...... geting cytoprotective Peptide.
@ast
Reduction of ischemia/reperfus ...... geting cytoprotective Peptide.
@en
prefLabel
Reduction of ischemia/reperfus ...... geting cytoprotective Peptide.
@ast
Reduction of ischemia/reperfus ...... geting cytoprotective Peptide.
@en
P2093
P2860
P356
P1476
Reduction of ischemia/reperfus ...... geting cytoprotective Peptide.
@en
P2093
Alan P Kypson
Chad R Frasier
Corinne A Watson
David A Brown
Joseph H Gorman
Kevin J Koomalsingh
Phillip A Bostian
Robert A Kloner
Robert C Gorman
Ruben C Sloan
P2860
P304
P356
10.1161/JAHA.112.001644
P577
2012-06-22T00:00:00Z